Effects of the Na+ channel blocker pilsicainide on the electrophysiologic properties of pulmonary veins in patients with atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 12, 2004, Pages 1396-1401

  Kumagai, Koichiro ^a   Tojo, Hideaki ^a   Noguchi, Hiroo ^a   Yasuda, Tomoo ^a   Ogawa, Masahiro ^a   Nakashima, Hideko ^a   Zhang, Bo ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antiarrhythmic agent; Atrium; Electrophysiology; Fibrillation; Veins

Indexed keywords

PILSICAINIDE; SODIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CLINICAL ARTICLE; DRUG EFFECT; ELECTROGRAPHY; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY VEIN; REFRACTORY PERIOD; STATISTICAL ANALYSIS;

ATRIAL FIBRILLATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; MIDDLE AGED; PULMONARY VEINS; SODIUM CHANNEL BLOCKERS; TREATMENT OUTCOME;

EID: 10944229735     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04430.x     Document Type: Article

References (26)

1. Suttorp MJ, Kingma JH, Lie AHL, Mast EG: Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.
2. Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T: Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators. Clin Cardiol 1996;19:409-412.
3. Kirchhof C, Wijffels M, Brugada J, Planellas J, Allessie M: Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol 1991;17:116-124.
4. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S: Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
5. Iwasa A, Okumura K, Tabuchi T, Tsuchiya T, Tsunoda R, Matsunaga T, Tayama S, Yasue H: Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity. Eur J Pharmacol 1998;356:31-40.
6. Kanki H, Mitamura H, Takatsuki S, Sueyoshi K, Shinagawa K, Sato T, Ogawa S: Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics. Cardiovasc Drugs Ther 1998;12:475-482.
7. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
8. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS: Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation., Circulation 1999;100:1879-1886.
9. Haissaguerre M, Jais P, Shah DC, Arentz T, Kalusche D, Takahashi A, Garrigue S, Hocini M, Peng JT, Clementy J: Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers. J Cardiovasc Electrophysiol 2000;11:2-10.
10. Kumagai K, Yasuda T, Tojo H, Noguchi H, Matsumoto N, Nakashima H, Gondo N, Saku K: Role of rapid focal activation in the maintenance of atrial fibrillation originating from the pulmonary veins. Pacing Clin Electrophysiol 2000;23:1823-1827.
11. Sasaki R, Inoue D, Ishibashi K, Inoue M, Shirayama T, Yamahara Y, Asayama J, Nakagawa M: Kinetics of frequency-dependent conduction delay by class 1 antiarrhythmic drugs in human atrium. J Cardiovasc Pharmacol 1995;25:953-960.
12. Atarashi H, Inoue H, Hiejima K, Hayakawa H: Conversion of recent-onset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation). The PSTAF Investigators. Am J Cardiol 1996;78:694-697.
13. Kumagai K, Abe H, Hiraki T, Nakashima H, Oginosawa Y, Ikeda H, Nakashima Y, Imaizumi T, Saku K: Single oral administration of pilsicainide versus infusion of disopyramide for termination of paroxysmal atrial fibrillation: a multicenter trial. Pacing Clin Electrophysiol 2000;23:1880-1882.
14. Wijffels MC, Dorland R, Mast F, Allessie MA: Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: Effects of cibenzoline, hydroquinidine, flecamide, and d-sotalol. Circulation 2000;102:260-267.
15. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J: A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-576.
16. Chen YJ, Chen SA, Chang MS, Lin CI: Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: Implication for the genesis of atrial fibrillation. Cardiovasc Res 2000;48:265-273.
17. Chou CC, Zhou S, Miyauchi Y, Pak HN, Okuyama Y, Fishbein MC, Karagueuzian HS, Chen PS: Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation. Am J Physiol Heart Circ Physiol 2004;286:1936-1945.
18. Jaïs P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R, Shah DC, Garrigue S, Raybaud F, Scavee C, Le Metayer P, Clementy J, Haissaguerre M: Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002;106:2479-2485.
19. Spach MS: Anisotropy of cardiac tissue: A major determinant of conduction? J Cardiovasc Electrophysiol 1999;10:887-980.
20. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH: Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:1525-1533.
21. Arora R, Verheule S, Scott L, Navarrete A, Katari V, Wilson E, Vaz D, Olgin JE: Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 2003;107:1816-1821.
22. Hamabe A, Okuyama Y, Miyauchi Y, Zhou S, Pak HN, Karagueuzian HS, Fishbein MC, Chen PS: Correlation between anatomy and electrical activation in canine pulmonary veins. Circulation 2003;107:1550-1555.
23. Saito T, Waki K, Becker AE: Left atrial myocardial extension onto pulmonary veins in humans: Anatomic observations relevant for atrial arrhythmias. J Cardiovasc Electrophysiol 2000;11:888-894.
24. Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-Quintana D: Architecture of the pulmonary veins: Relevance to radiofrequency ablation. Heart 2001;86:265-270.
25. Hocini M, Ho SY, Kawara T, Linnenbank AC, Potse M, Shah D, Jais P, Janse MJ, Haissaguerre M, De Bakker JM: Electrical conduction in canine pulmonary veins: Electrophysiological and anatomic correlation. Circulation 2002;105:2442-2448.
26. Oral H, Knight BP, Ozaydin M, Chugh A, Lai SW, Scharf C, Hassan S, Greenstein R, Han JD, Pelosi F Jr, Strickberger SA, Morady F: Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: Feasibility and mechanistic insights. Circulation 2002:106:1256-1262.